Question 1

What is the catalog number for Anti-FABP6 Antibody (8D150)?

Accepted Answer

The catalog number for Anti-FABP6 Antibody (8D150) is TMAY-02384.

Question 2

What sizes are available for Anti-FABP6 Antibody (8D150)?

Accepted Answer

Anti-FABP6 Antibody (8D150) is available in the following size(s): 100 µL.

Question 3

Is Anti-FABP6 Antibody (8D150) in stock?

Accepted Answer

Anti-FABP6 Antibody (8D150) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures Anti-FABP6 Antibody (8D150)?

Accepted Answer

Anti-FABP6 Antibody (8D150) is manufactured by Molfinity.

Question 5

What is the estimated delivery time for Anti-FABP6 Antibody (8D150)?

Accepted Answer

Estimated delivery time for Anti-FABP6 Antibody (8D150) is approximately 10 business day(s), depending on your location.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 8

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Anti-FABP6 Antibody (8D150)

Product Specifications

Bioactivity

Shipping Conditions

Storage Temperature

Frequently Asked Questions

Explore Other Products

H-D-Val-D-Val-OH

Sclareol (~90%)

3-Nitro-1-pyrenol-d8

NTE (PNPLA6) (NM_001166111) Human Recombinant Protein

2-[[3,4,6-Tri-O-acetyl-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl]oxy]acetic Acid

Olokizumab Biosimilar - Research Grade